newsfilter
← Latest News
GlobeNewswire·

Principia Announces AAD Late Breaker Research Presentation of its Pemphigus Phase 2 Part B Trial

SOUTH SAN FRANCISCO, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated...